October 12, 2017

BASF does not anticipate any health hazards

  • Analysis of foams show low DCB levels
  • Intensive dialog with customers, associations and consumers

BASF experts have conducted initial tests on foams as part of a risk assessment. The results and subsequent calculations show that health hazards are not anticipated. BASF is providing the responsible authorities and the relevant associations with the details of the assessment.

Of the 7,500 metric tons of TDI, which have a higher dichlorobenzene level, about two-thirds were not yet further processed. The withdrawal of the product has started in close cooperation with the customers. A team of around 75 specialists is working together with customers to clarify open questions.

About 300 calls, mainly from consumers, have been made to BASF’s hotline for customers and consumers. Most of the questions have been about finished products such as mattresses. BASF is in close contact with the relevant associations for mattresses and foam producers in order to find a solution as quickly as possible.

Note to editors:
The telephone hotline for customers and consumers can be reached between 8 a.m. and 6 p.m. under +49 621 60-21919.

About BASF
At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 114,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of about €58 billion in 2016. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (BAS). Further information at www.basf.com.


Last Update October 12, 2017